The Clinical and Research Team at OMEICOS Therapeutics is responsible for designing, executing, and overseeing clinical trials and research initiatives to develop and validate novel molecules for the treatment and prevention of atrial fibrillation. They ensure that studies comply with regulatory standards, analyze clinical data, and collaborate with cross-functional teams to advance therapeutic candidates from the lab to patient care.
View all